Delivery Order SPE2DR25D2104-SPE2DR26F3QBA
Award Date 11/26/25
Potential Completion Date 11/28/25
Potential Value $10K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- On December 1, 2025, the Defense Logistics Agency awarded a delivery order valued at $26,609.49 to AmerisourceBergen Drug Corp for the supply of Zepbound 10 mg/0.5 ml pen injectors. This firm fixed-price delivery order, with an ultimate completion date of December 2, 2025, represents a competitive award with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Zepbound, a GLP-1 receptor agonist used in diabetes and...
- The Defense Logistics Agency awarded a delivery order valued at $5,570.12 to AmerisourceBergen Drug Corp on May 12, 2025, for the supply of Zepbound 10 mg/0.5 mL pen injectors. This non-competitive, firm fixed-price delivery order represents a single transaction under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The product will be delivered to AmerisourceBergen's distribution facility in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,752.01 on October 20, 2025, for the supply of Zepbound 10 mg/0.5 mL pen injectors. This is a firm fixed price, non-competitive set-aside delivery order with an ultimate completion date of October 21, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Zepbound is a GLP-1 receptor agonist used for weight management and represents the company's ongoing...
- The Defense Logistics Agency awarded a delivery order valued at $13,289.04 to AmerisourceBergen Drug Corp on December 4, 2025, for the supply of Zepbound 10 mg/0.5 ml pen injectors. This firm fixed-price delivery order, which is non-set-aside, will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of December 5, 2025. Zepbound is a GLP-1 receptor agonist medication used in weight management, reflecting the federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 6, 2025, for the supply of Zepbound 5 mg/0.5 mL pen injectors with a ceiling value of $25,215.16. This is a firm fixed price delivery order with no set-aside designation, reflecting a competitively awarded contract. The order is set for ultimate completion by November 7, 2025, and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania location. Zepbound is a GLP-1 receptor agonist used...
- The Defense Logistics Agency awarded a $13,150.18 delivery order to AmerisourceBergen Drug Corp for Zepbound 15 mg/0.5 ml pen injectors on September 9, 2025, with an ultimate completion date of September 10, 2025. This firm fixed-price delivery order, which was competitively awarded with no set-aside designation, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Zepbound is a GLP-1 receptor agonist used for weight management, reflecting the federal...
- The Defense Logistics Agency awarded a delivery order valued at $45,827.22 to AmerisourceBergen Drug Corp for the supply of Zepbound 10 mg/0.5 mL pen injectors on October 30, 2025, with completion scheduled for October 31, 2025. This firm fixed-price delivery order, issued without a set-aside designation, represents a competitive award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,625.80 to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Zepbound 10 mg/0.5 mL pen injectors. The contract represents a firm fixed price delivery order with an ultimate completion date of August 15, 2025, and was competitively awarded without set-aside provisions. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical...
- On November 6, 2025, the Defense Logistics Agency awarded a delivery order valued at $3,188.64 to AmerisourceBergen Drug Corp for the supply of Zepbound 10 mg/0.5 ml pen injectors (0.5 ml units). This competitive award represents a firm fixed-price delivery order with no set-aside designation and an ultimate completion date of November 7, 2025. The contract is performed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $122,590.65 on September 24, 2025, for the supply of Zepbound 5 mg/0.5 mL pen injectors. This is a firm fixed-price contract with a completion date of September 25, 2025, and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The contract was...